newsfilter
← Latest News
Business Wire·

Five Prime Therapeutics Announces Timing of Its Fourth Quarter and Full Year 2019 Results Conference Call

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, will report its fourth quarter and full year 2019 operational and financial results on Thursday, February 27, 2020 after the U.S. financial markets close. Five Prime will also host a conference call and live audio webcast on Thursday, February 27, 2020 at 4:30 p.m. (ET) / 1:30 p.m. (PT) to provide a general business update and dicuss the company’s financial results.